Jefferies Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Jefferies Financial Group's XERS Position: Q3 2026 in Review
Jefferies Financial Group sold out of Xeris Biopharma Holdings (XERS) in Q3 2026, closing a stake of 293,670 shares — an estimated $2.33M sold.
Jefferies Financial Group first reported a position in XERS in Q4 2025 and held it in 3 quarters. The position peaked at $2.33M in Q2 2026. 248 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Jefferies Financial Group reported no remaining Xeris Biopharma Holdings position as of Q3 2026 after selling out during the quarter.
- Jefferies Financial Group sold 293,670 Xeris Biopharma Holdings shares in Q3 2026, an estimated $2.33M.
- Jefferies Financial Group first reported a position in Xeris Biopharma Holdings in Q4 2025 and held it in 3 quarters.
- Jefferies Financial Group's Xeris Biopharma Holdings position peaked at $2.33M in Q2 2026.
- 248 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.